Promoter hypermethylation of SFRP1 as a prognostic and predictive blood-based biomarker in patients with stage IV pancreatic ductal adenocarcinoma.

Benjamin E. Stubbe, Stine D. Henriksen, Poul H. Madsen, Anders C. Larsen, Henrik B. Krarup, Inge S. Pedersen, Julia S. Johansen, Carsten P. Hansen, Ole Thorlacius-Ussing

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberB047
JournalCancer Research
Volume82
Issue numberSuppl. 22
Number of pages1
ISSN0008-5472
DOIs
Publication statusPublished - 15 Nov 2022
EventAACR Special Conference: Pancreatic Cancer - Sheraton Boston Hotel, Boston, United States
Duration: 13 Sept 202216 Sept 2022
https://www.aacr.org/professionals/meetings/previous-aacr-meetings/previous-aacr-meetings-2022/

Conference

ConferenceAACR Special Conference: Pancreatic Cancer
LocationSheraton Boston Hotel
Country/TerritoryUnited States
CityBoston
Period13/09/202216/09/2022
Internet address

Bibliographical note

Abstract No. B047

Cite this